Management of multidrug-resistant tuberculosis in Italy
OBJECTIVES: To determine the main features, adherence to WHO guidelines and the outcomes of multidrug-resistant tuberculosis (MDR-TB) patients enrolled from January 1995 to December 1999.
DESIGN: Observational study, preceded by proficiency testing, according to WHO recommendations. Results were stratified by appropriate and inappropriate regimens (< three active drugs). Analysis of the outcomes was performed according to adequacy of treatment. Analysis of risk factors and factors predicting treatment outcomes was performed using univariate and multivariate analysis (level of significance P < 0.05).
RESULTS: One hundred and twenty-seven MDR patients were diagnosed. The overall success rate was low (39%). Seventy per cent of cases were treated with at least three active drugs. Factors predicting treatment success were new MDR-TB cases (OR 3.45; 95%CI 1.22–9.78; P < 0.05) and treatment for ≥ 12 months (OR 5.03; 95%CI 1.65–15. 31; P < 0.05). Immigration and HIV infection were the main risk factors among new MDR-TB cases.
CONCLUSION: The best available treatment should be provided to all newly diagnosed MDR-TB patients, avoiding the use of poorly modified regimens. MDR-TB patients should be referred to highly specialised centres.
Keywords: Italy; MDR; management; tuberculosis
Document Type: Regular Paper
Affiliations: 1: Respiratory Diseases Section, University of Modena and Reggio Emilia, Modena, Italy 2: Pneumology Department, CPA-ASL4 of Piemonte, Piemonte Region, Italy 3: Emerging Infectious Diseases Unit, San Raffaele-Turro Hospital, Milano, Italy 4: Tuberculosis Department, E. Morelli Hospital, Sondalo, Italy 5: Pneumology Department, Careggi Hospital, Firenze, Italy 6: Department of Pulmonary Diseases, University of Terni, Terni, Italy 7: Pneumology Department, Vecchiazzano Hospital, Forlì, Italy 8: Villa Marelli Institute, Niguarda Hospital, Reference Centre for Tuberculosis Lombardia Region, Milano, Italy 9: Clinical Epidemiology of Respiratory Diseases Service/Pneumology Department, WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri Care and Research Institute, Tradate, Italy
Publication date: 01 May 2005
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content